Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism

This publication has 15 references indexed in Scilit:

• Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous Thromboembolism
  Annals of Internal Medicine, 1999
• Pathophysiology of the Thrombophilic State in the Cancer Patient
  Seminars in Thrombosis and Hemostasis, 1999
• The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient
  Seminars in Thrombosis and Hemostasis, 1999
• A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
  Blood, 1999
• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• Clinical significance of the FV:Q506 mutation in unselected oncology patients
  The American Journal of Medicine, 1996
• Development of resistance to activated protein C during pregnancy
  British Journal of Haematology, 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]
  Blood, 1993
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993